Navin Fluorine International Limited delivered robust financial results for Q1FY27, reporting a consolidated net profit after tax (PAT) of ₹243.31 crore, a 108% year-on-year increase from ₹117.17 crore in Q1FY26. The growth was underpinned by a 44% rise in consolidated revenue from operations to ₹1,045.08 crore, driven by volume expansion and higher realizations across its High Performance Products (HPP), Specialty Chemicals, and Contract Development and Manufacturing Organisation (CDMO) verticals. The Board of Directors approved the results on August 05, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Operating profitability expanded significantly, with operating EBITDA rising 73% to ₹357.07 crore, pushing the operating EBITDA margin up by 566 basis points to 34.2%. Profit before tax (PBT) jumped 105% to ₹318.36 crore. The strong bottom-line performance reflects improved operating leverage, as total expenses grew at a slower pace than revenue. Statutory auditors Price Waterhouse Chartered Accountants LLP provided a limited review report on the unaudited financial results.

Segment Performance

Revenue growth was broad-based across all business units:

• HPP: Revenue grew 33% YoY to ₹540 crore, supported by constructive pricing for hydrofluoroolefins (HFCs) and ramp-up of the anhydrous hydrofluoric acid (AHF) facility.
• Specialty Chemicals: Revenue surged 48% YoY to ₹325 crore, aided by strong order visibility and scale-up of existing molecules.
• CDMO: Revenue nearly doubled with an 82% YoY increase to ₹180 crore, driven by deeper engagement with European partners and increased demand for existing molecules.

On a standalone basis, the holding company reported a net profit of ₹190.64 crore, up 69% from ₹112.76 crore in the prior year quarter. Standalone revenue increased 28% to ₹694.68 crore.

Capital Expenditure and Growth Initiatives

The company outlined a significant capital expenditure program aimed at capacity expansion and new product launches. Key initiatives include:

• HFC Capacity Expansion: A capex of ₹236.50 crore is underway to add capacity equivalent to 15,000 MTPA of R32, expected to be commissioned by Q3FY27. This project is funded through internal accruals.
• Advanced Materials: Navin Fluorine is investing ₹90 crore to set up adoption capacities for advanced materials in data centers, electronics, defence, and semiconductors at its Surat unit. This project is targeted for completion by Q2FY28.
• CDMO Expansion: Phase II of the cGMP4 facility, with a capex of ₹125 crore, has been initiated and is expected to operationalize by Q4FY27. This follows Phase I which became operational in Q3FY26.
• Chemours Project: An initial commercial capacity for liquid cooling products is being set up with a capex of ₹120 crore (35% funded by customer), targeted for commissioning by Q2FY27.
• Renewable Energy: The company invested ₹15.73 crore for a 14.9 MW hybrid power plant to meet over 60% of its energy needs from renewable sources.

What the Numbers Show

The divergence between revenue growth (44%) and expense management highlights improved operating leverage for Navin Fluorine International Limited. While raw material costs rose to ₹449.75 crore from ₹307.71 crore, the company successfully contained other expenses, leading to a substantial expansion in operating margins. The CDMO segment’s 82% revenue growth indicates successful execution of its strategy to deepen ties with global innovators, while the HPP segment benefits from favorable global demand-supply dynamics for low-GWP gases. The consistent quarter-on-quarter growth in PAT over the last four quarters underscores sustained operational momentum.

Navin Fluorine International has announced a partnership with the Defence Research and Development Organisation (DRDO) aimed at enabling the large-scale local production of Sodium Borohydride, a specialised chemical compound with significant industrial and defence applications.

Strategic Collaboration with DRDO

The partnership between Navin Fluorine International and DRDO marks a notable development in India's efforts to indigenise the production of critical chemicals. Sodium Borohydride is widely used as a reducing agent across various industries, including pharmaceuticals, fine chemicals, and defence-related applications. By collaborating with DRDO, Navin Fluorine International is positioning itself as a key domestic supplier capable of producing this compound at scale.

Key Partnership Details

The following table outlines the core aspects of this collaboration:

Significance of Domestic Production

The initiative aligns with broader national objectives of reducing import dependence for specialised chemicals. Sodium Borohydride, given its utility in defence and high-value industrial processes, has historically been sourced through imports. A domestic production capability of this chemical at large quantities could strengthen supply chain resilience and support self-reliance in critical material inputs.

Navin Fluorine International's collaboration with DRDO reflects the company's commitment to advancing India's domestic chemical manufacturing capabilities, particularly in segments that intersect with strategic and defence requirements.